Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid death. Academic Article uri icon



  • Rifampicin, which inhibits bacterial RNA polymerase, provides one of the most effective treatments for tuberculosis. Inhibition of the transcription termination factor Rho is used to treat some bacterial infections, but its importance varies across bacteria. Here we show that Rho of Mycobacterium tuberculosis functions to both define the 3' ends of mRNAs and silence substantial fragments of the genome. Brief inactivation of Rho affects over 500 transcripts enriched for genes of foreign DNA elements and bacterial virulence factors. Prolonged inactivation of Rho causes extensive pervasive transcription, a genome-wide increase in antisense transcripts, and a rapid loss of viability of replicating and non-replicating M. tuberculosis in vitro and during acute and chronic infection in mice. Collectively, these data suggest that inhibition of Rho may provide an alternative strategy to treat tuberculosis with an efficacy similar to inhibition of RNA polymerase.

publication date

  • March 28, 2017



  • Microbial Viability
  • Mycobacterium tuberculosis
  • Rho Factor
  • Transcription, Genetic


PubMed Central ID

  • PMC5379054

Scopus Document Identifier

  • 85016414293

Digital Object Identifier (DOI)

  • 10.1038/ncomms14731

PubMed ID

  • 28348398

Additional Document Info


  • 8